Insider trades
Natarajan Sethuraman, President of Entrada Therapeutics TRDA, has filed 0 purchases and 21 sales on the open market. Over the past 12 months that comes to a net sale of $398.7K. The latest trade was on 05/04.
Natarajan Sethuraman
President, Research & Develop
- Company
- Entrada Therapeutics TRDA
- First filing
- 23/03/03
- Trades
- 47 trades
- Buys / sales
- 0 / 21
- 12-month net buying
- −$398.7K
- Last trade
- 05/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/04 | 05/04 | 25,907 sh | $15.39 | $398,708.73 | −10.7% | |
TRDA | Open-market sale10b5-1 plan | 24/11/29–24/12/03 | 24/12/03 | 15,891 sh3 trades | $20.18avg. | $320,638.33 | −9.9% |
TRDA | Open-market sale10b5-1 plan | 24/11/11–24/11/13 | 24/11/13 | 4,109 sh2 trades | $20.03avg. | $82,302.09 | −2.5% |
TRDA | Open-market sale10b5-1 plan | 24/11/04–24/11/06 | 24/11/06 | 18,219 sh4 trades | $18.62avg. | $339,294.5 | −9.9% |
| Open-market sale10b5-1 plan | 24/10/16 | 24/10/18 | 600 sh | $18.00 | $10,800 | −0.3% | |
TRDA | Open-market sale10b5-1 plan | 24/09/06–24/09/09 | 24/09/10 | 3,242 sh2 trades | $15.12avg. | $49,011.78 | −1.7% |
TRDA | Open-market sale10b5-1 plan | 24/07/12–24/07/15 | 24/07/16 | 1,238 sh2 trades | $18.00avg. | $22,284 | −0.7% |
TRDA | Open-market sale10b5-1 plan | 24/05/16–24/05/20 | 24/05/20 | 18,980 sh3 trades | $15.16avg. | $287,700.95 | −9.1% |
TRDA | Open-market sale10b5-1 plan | 23/07/10–23/07/11 | 23/07/12 | 17,878 sh2 trades | $18.03avg. | $322,398.08 | −10.4% |
| Open-market sale10b5-1 plan | 23/04/17 | 23/04/19 | 3,961 sh | $18.00 | $71,298 | −2.3% |